European Union:
EMA Establishing Task Force On International Standards For Identification Of Products
To print this article, all you need is to be registered or login on Mondaq.com.
EMA is establishing a task force for the
implementation of international standards for the identification of
medicinal products for human use in the EU. The task force will be
made up of representatives of the agency, national competent
authorities, the pharmaceutical industry, and service providers.
Parties interested in participating are invited to
submit their expressions of interest by March 6,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from European Union
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
